IDEXX Historical Balance Sheet

IDXX Stock

USD 459.86 3.80 0.82%

Trend analysis of IDEXX Laboratories balance sheet accounts such as Total Current Liabilities of 1.1 B or Total Stockholder Equity of 1.7 B provides information on IDEXX Laboratories' total assets, liabilities, and equity, which is the actual value of IDEXX Laboratories to its prevalent stockholders. By breaking down trends over time using IDEXX Laboratories balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining IDEXX Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether IDEXX Laboratories is a good buy for the upcoming year.

IDEXX Laboratories Inventory

400.97 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

About IDEXX Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of IDEXX Laboratories at a specified time, usually calculated after every quarter, six months, or one year. IDEXX Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of IDEXX Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which IDEXX currently owns. An asset can also be divided into two categories, current and non-current.

IDEXX Laboratories Balance Sheet Chart

At this time, IDEXX Laboratories' Inventory is fairly stable compared to the past year. Other Current Assets is likely to rise to about 269 M in 2025, whereas Total Assets are likely to drop slightly above 1.1 B in 2025.

Total Assets Other Current Liab Property Plant And Equipment Net Capital Lease Obligations

Add Fundamental

Total Assets

Total assets refers to the total amount of IDEXX Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in IDEXX Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Capital Lease Obligations

IDEXX Laboratories capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to IDEXX Laboratories asset purchases. For example, IDEXX Laboratories can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as IDEXX Laboratories control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Most accounts from IDEXX Laboratories' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.At this time, IDEXX Laboratories' Inventory is fairly stable compared to the past year. Other Current Assets is likely to rise to about 269 M in 2025, whereas Total Assets are likely to drop slightly above 1.1 B in 2025.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	364.7M	372.4M	752.1M	789.7M
Total Assets	2.7B	3.3B	1.9B	1.1B

Other Current Liab Total Assets

IDEXX Laboratories balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Non Current Liabilities Total	Intangible Assets	Short Long Term Debt Total	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock
Total Assets		0.38	0.63	0.36	0.7	0.52	0.51	0.75	0.51	0.94	0.37	0.38	0.79	-0.39	0.69	0.32	-0.59	0.79	0.71	0.74	0.63	0.66	0.27	0.54	0.68	0.7
Other Current Liab	0.38		0.69	0.77	0.91	-0.13	0.9	0.86	0.2	0.23	-0.63	0.08	0.84	-0.35	0.87	0.96	-0.89	0.12	0.84	0.03	0.67	0.03	-0.13	0.9	0.45	0.37
Total Current Liabilities	0.63	0.69		0.33	0.76	0.5	0.6	0.8	0.17	0.48	-0.23	0.37	0.74	-0.32	0.8	0.75	-0.69	0.63	0.83	0.41	0.61	0.64	0.61	0.58	0.66	0.65
Total Stockholder Equity	0.36	0.77	0.33		0.77	-0.51	0.93	0.66	0.47	0.23	-0.5	0.07	0.74	-0.08	0.79	0.72	-0.84	-0.2	0.73	-0.25	0.7	-0.33	-0.42	0.86	0.26	0.19
Property Plant And Equipment Net	0.7	0.91	0.76	0.77		0.09	0.91	0.96	0.37	0.58	-0.32	0.19	0.97	-0.43	0.96	0.86	-0.93	0.39	0.93	0.31	0.74	0.28	-0.01	0.92	0.56	0.52
Net Debt	0.52	-0.13	0.5	-0.51	0.09		-0.24	0.24	-0.17	0.58	0.56	0.22	0.16	-0.39	0.09	-0.12	0.09	0.91	0.13	0.85	-0.02	0.96	0.76	-0.15	0.34	0.43
Retained Earnings	0.51	0.9	0.6	0.93	0.91	-0.24		0.84	0.39	0.38	-0.48	0.04	0.89	-0.27	0.93	0.86	-0.98	0.06	0.85	-0.03	0.79	-0.06	-0.19	0.93	0.39	0.32
Accounts Payable	0.75	0.86	0.8	0.66	0.96	0.24	0.84		0.23	0.66	-0.2	0.12	0.97	-0.48	0.94	0.79	-0.89	0.51	0.89	0.42	0.77	0.39	0.09	0.89	0.57	0.54
Cash	0.51	0.2	0.17	0.47	0.37	-0.17	0.39	0.23		0.33	-0.01	0.71	0.36	0.13	0.34	0.22	-0.36	0.14	0.53	0.12	0.35	0.06	-0.07	0.34	0.49	0.48
Non Current Assets Total	0.94	0.23	0.48	0.23	0.58	0.58	0.38	0.66	0.33		0.57	0.16	0.69	-0.36	0.57	0.14	-0.46	0.81	0.52	0.81	0.5	0.67	0.23	0.41	0.51	0.59
Non Currrent Assets Other	0.37	-0.63	-0.23	-0.5	-0.32	0.56	-0.48	-0.2	-0.01	0.57		-0.03	-0.16	0.02	-0.32	-0.7	0.41	0.53	-0.34	0.63	-0.19	0.48	0.21	-0.44	0.01	0.14
Cash And Short Term Investments	0.38	0.08	0.37	0.07	0.19	0.22	0.04	0.12	0.71	0.16	-0.03		0.16	0.06	0.17	0.12	-0.04	0.35	0.49	0.25	0.07	0.4	0.39	0.12	0.47	0.48
Net Receivables	0.79	0.84	0.74	0.74	0.97	0.16	0.89	0.97	0.36	0.69	-0.16	0.16		-0.47	0.96	0.75	-0.92	0.47	0.91	0.4	0.76	0.34	0.01	0.89	0.54	0.51
Common Stock Shares Outstanding	-0.39	-0.35	-0.32	-0.08	-0.43	-0.39	-0.27	-0.48	0.13	-0.36	0.02	0.06	-0.47		-0.34	-0.22	0.35	-0.42	-0.31	-0.49	-0.03	-0.37	0.02	-0.4	0.1	0.16
Inventory	0.69	0.87	0.8	0.79	0.96	0.09	0.93	0.94	0.34	0.57	-0.32	0.17	0.96	-0.34		0.84	-0.95	0.36	0.93	0.22	0.83	0.27	0.09	0.89	0.56	0.52
Other Current Assets	0.32	0.96	0.75	0.72	0.86	-0.12	0.86	0.79	0.22	0.14	-0.7	0.12	0.75	-0.22	0.84		-0.86	0.09	0.82	-0.05	0.67	0.05	0.02	0.83	0.5	0.42
Other Stockholder Equity	-0.59	-0.89	-0.69	-0.84	-0.93	0.09	-0.98	-0.89	-0.36	-0.46	0.41	-0.04	-0.92	0.35	-0.95	-0.86		-0.2	-0.86	-0.09	-0.82	-0.09	0.07	-0.9	-0.46	-0.39
Total Liab	0.79	0.12	0.63	-0.2	0.39	0.91	0.06	0.51	0.14	0.81	0.53	0.35	0.47	-0.42	0.36	0.09	-0.2		0.43	0.95	0.23	0.97	0.62	0.14	0.55	0.63
Total Current Assets	0.71	0.84	0.83	0.73	0.93	0.13	0.85	0.89	0.53	0.52	-0.34	0.49	0.91	-0.31	0.93	0.82	-0.86	0.43		0.29	0.71	0.36	0.17	0.85	0.63	0.6
Non Current Liabilities Total	0.74	0.03	0.41	-0.25	0.31	0.85	-0.03	0.42	0.12	0.81	0.63	0.25	0.4	-0.49	0.22	-0.05	-0.09	0.95	0.29		0.09	0.88	0.38	0.1	0.42	0.51
Intangible Assets	0.63	0.67	0.61	0.7	0.74	-0.02	0.79	0.77	0.35	0.5	-0.19	0.07	0.76	-0.03	0.83	0.67	-0.82	0.23	0.71	0.09		0.09	0.04	0.72	0.68	0.61
Short Long Term Debt Total	0.66	0.03	0.64	-0.33	0.28	0.96	-0.06	0.39	0.06	0.67	0.48	0.4	0.34	-0.37	0.27	0.05	-0.09	0.97	0.36	0.88	0.09		0.76	0.02	0.47	0.56
Short Term Debt	0.27	-0.13	0.61	-0.42	-0.01	0.76	-0.19	0.09	-0.07	0.23	0.21	0.39	0.01	0.02	0.09	0.02	0.07	0.62	0.17	0.38	0.04	0.76		-0.23	0.36	0.43
Property Plant And Equipment Gross	0.54	0.9	0.58	0.86	0.92	-0.15	0.93	0.89	0.34	0.41	-0.44	0.12	0.89	-0.4	0.89	0.83	-0.9	0.14	0.85	0.1	0.72	0.02	-0.23		0.38	0.31
Common Stock Total Equity	0.68	0.45	0.66	0.26	0.56	0.34	0.39	0.57	0.49	0.51	0.01	0.47	0.54	0.1	0.56	0.5	-0.46	0.55	0.63	0.42	0.68	0.47	0.36	0.38		0.97
Common Stock	0.7	0.37	0.65	0.19	0.52	0.43	0.32	0.54	0.48	0.59	0.14	0.48	0.51	0.16	0.52	0.42	-0.39	0.63	0.6	0.51	0.61	0.56	0.43	0.31	0.97

Click cells to compare fundamentals

IDEXX Laboratories Account Relationship Matchups

IDEXX Laboratories balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.3B	2.4B	2.7B	3.3B	1.9B	1.1B
Other Current Liab	355.2M	396.4M	364.7M	372.4M	752.1M	789.7M
Total Current Liabilities	582.8M	763.6M	1.2B	951.5M	1.1B	1.1B
Total Stockholder Equity	632.1M	690.0M	608.7M	1.5B	1.6B	1.7B
Property Plant And Equipment Net	555.2M	587.7M	649.5M	817.7M	829.3M	870.7M
Net Debt	524.6M	779.2M	1.2B	613.4M	(22.6M)	(21.5M)
Retained Earnings	2.2B	2.9B	3.6B	4.4B	5.3B	5.6B
Accounts Payable	74.6M	116.1M	110.2M	110.6M	114.2M	119.9M
Cash	383.9M	144.5M	112.5M	453.9M	288.3M	151.8M
Non Current Assets Total	1.2B	1.5B	1.6B	1.8B	493.6M	530.8M
Non Currrent Assets Other	337.2M	397.4M	425.6M	333.0M	(852.4M)	(809.8M)
Cash And Short Term Investments	383.9M	144.5M	112.5M	453.9M	288.3M	185.3M
Net Receivables	374.7M	425.6M	490.9M	529.5M	473.6M	497.3M
Common Stock Shares Outstanding	86.7M	86.6M	84.6M	84.0M	83.1M	94.1M
Liabilities And Stockholders Equity	2.3B	2.4B	2.7B	3.3B	3.3B	3.5B
Inventory	209.9M	269.0M	367.8M	380.3M	381.9M	401.0M
Other Current Assets	94.2M	116.6M	130.2M	131.5M	256.2M	269.0M
Other Stockholder Equity	(1.5B)	(2.2B)	(2.9B)	(2.9B)	(3.7B)	(3.5B)
Total Liab	1.7B	1.7B	2.1B	1.8B	630.2M	690.8M
Total Current Assets	1.1B	955.7M	1.1B	1.5B	1.4B	1.5B
Non Current Liabilities Total	1.1B	983.6M	902.2M	823.8M	109.1M	103.7M
Intangible Assets	52.5M	99.0M	97.7M	84.5M	111.7M	76.3M
Short Long Term Debt Total	908.5M	923.7M	1.3B	1.1B	265.6M	457.1M
Short Term Debt	67.7M	168.4M	674.4M	344.8M	167.8M	210.7M
Property Plant And Equipment Gross	646.3M	1.3B	649.5M	1.6B	1.7B	1.7B
Accumulated Other Comprehensive Income	(53.6M)	(53.5M)	(77.8M)	(71.2M)	(93.6M)	(89.0M)
Common Stock Total Equity	10.6M	10.6M	10.7M	10.7M	12.3M	9.0M
Common Stock	10.6M	10.7M	10.7M	10.8M	10.8M	9.3M
Other Assets	240.2M	676.7M	893.9M	387.5M	445.6M	467.9M
Treasury Stock	(2.3B)	(2.6B)	(2.8B)	(3.6B)	(3.2B)	(3.1B)
Property Plant Equipment	533.8M	555.2M	587.7M	649.5M	746.9M	784.2M
Current Deferred Revenue	42.6M	40.0M	37.9M	37.2M	33.8M	25.5M
Good Will	243.3M	359.3M	361.8M	366.0M	405.1M	216.4M
Other Liab	162.8M	220.5M	208.4M	106.6M	122.6M	83.3M
Long Term Debt	858.5M	775.2M	694.4M	622.9M	449.8M	386.5M
Net Tangible Assets	(120.7M)	336.2M	690.0M	149.3M	134.3M	141.1M
Retained Earnings Total Equity	1.6B	2.2B	2.9B	3.6B	4.1B	4.3B
Long Term Debt Total	698.9M	858.5M	775.2M	694.4M	798.5M	502.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IDEXX Historical Balance Sheet

IDEXX Laboratories Inventory

400.97 Million

About IDEXX Balance Sheet Analysis

IDEXX Laboratories Balance Sheet Chart

Total Assets

Property Plant And Equipment Net

Capital Lease Obligations

IDEXX Laboratories balance sheet Correlations

IDEXX Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

IDEXX Laboratories balance sheet Accounts

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 0.97	Property Plant And Equipment Net
Net Receivables	+ 0.97	Accounts Payable
Short Long Term Debt Total	+ 0.97	Total Liab
Common Stock	+ 0.97	Common Stock Total Equity
Other Current Assets	+ 0.96	Other Current Liab
Accounts Payable	+ 0.96	Property Plant And Equipment Net

Other Stockholder Equity	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.95	Inventory
Other Stockholder Equity	- 0.93	Property Plant And Equipment Net
Other Stockholder Equity	- 0.92	Net Receivables
Property Plant And Equipment Gross	- 0.9	Other Stockholder Equity
Other Stockholder Equity	- 0.89	Accounts Payable